AG
VIVO

Advisor Group’s Meridian Bioscience Inc VIVO Stock Holding History

Advisor Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-242
Closed -$4K – 5425
2019
Q1 		$4K Buy
+242
New +$4.03K ﹤0.01% 4799
2018
Q3 		– Sell
-17,195
Closed -$273K – 5281
2018
Q2 		$273K Buy
17,195
+7,083
+70% +$106K ﹤0.01% 1748
2018
Q1 		$144K Sell
10,112
-3,334
-25% -$49.3K ﹤0.01% 2249
2017
Q4 		$188K Buy
13,446
+4,932
+58% +$72.2K ﹤0.01% 2048
2017
Q3 		$121K Buy
8,514
+794
+10% +$11.3K ﹤0.01% 2253
2017
Q2 		$122K Buy
7,720
+1,537
+25% +$22.1K ﹤0.01% 2145
2017
Q1 		$86K Buy
6,183
+6,017
+3,625% +$84.1K ﹤0.01% 2281
2016
Q4 		$3K Hold
166
– – ﹤0.01% 4154
2016
Q3 		$3K Buy
166
+55
+50% +$1.08K ﹤0.01% 4097
2016
Q2 		$2K Buy
+111
New +$2.18K ﹤0.01% 4141

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Group's VIVO Position: Q2 2019 in Review

Advisor Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 242 shares — an estimated $4K sold.

Advisor Group first reported a position in VIVO in Q2 2016 and held it in 10 quarters. The position peaked at $273K in Q2 2018. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

  • Advisor Group reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 242 Meridian Bioscience Inc shares in Q2 2019, an estimated $4K.
  • Advisor Group first reported a position in Meridian Bioscience Inc in Q2 2016 and held it in 10 quarters.
  • Advisor Group's Meridian Bioscience Inc position peaked at $273K in Q2 2018.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.